Clinical Trial Update: Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase III trial evaluating L-Cysteine in patients with erythropoietic protoporphyria. It indicates the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• L-cysteine (L-cysteine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Erythropoietic Protoporphyria | Phase 3 | Status: COMPLETED